Bone Biologics Corp (BBLG) Stock Price, Quote, News & History

BBLGNASDAQ
$0.6402
-0.0031-0.48%
At close: Aug 19, 5:00 PM EST
$0.6160
-0.0242-3.78%
After Hours: 7:12 PM EST
Earnings: Q2 2026 Earnings were released on Fri Aug 14th, after the market close
Loading...

Key Statistics

Open
$0.63
Close
$0.64
Volume / Avg.
139.79K / 320.39K
Day Range
$0.61 - $0.64
52 Wk Range
0.61 - 4.13
Market Cap
$1.12M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
23
Short Interest
1.16%
Days to Cover
1

Recent Bone Biologics Corp News

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-2.63M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
20.18K
Free Cash Flow (TTM)
-2.63M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-2.61M

Valuation Metrics

Enterprise Value
-$2.87M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.29
Earnings Yield % (TTM)
-43.81%
Earnings Yield % (FWD)
-192.46%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.17

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$4.03M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$0.63
Close
$0.64
Volume / Avg.
139.79K / 320.39K
Day Range
$0.61 - $0.64
52 Wk Range
0.61 - 4.13
Market Cap
$1.12M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
23
Short Interest
1.16%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombin...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Bone Biologics (BBLG) stock?

A

You can purchase shares of Bone Biologics (NASDAQ:BBLG) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Bone Biologics (BBLG) competitors?

Q

What is the forecast, or price target, for Bone Biologics (BBLG) stock?

A

There is no analysis for Bone Biologics to provide a consensus price target.

Q

What is the current price for Bone Biologics (BBLG)?

A

The stock price for Bone Biologics (NASDAQ: BBLG) is $0.616 last updated August 19, 2026 at 7:12 PM EDT.

Q

Does Bone Biologics (BBLG) pay a dividend?

A

There are no upcoming dividends for Bone Biologics.

Q

When is Bone Biologics (NASDAQ:BBLG) reporting earnings?

A

Bone Biologics does not have any upcoming earnings scheduled.

Q

Is Bone Biologics (BBLG) going to split?

A

There is no upcoming split for Bone Biologics.

Q

What sector and industry does Bone Biologics (BBLG) operate in?

A

Bone Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.